Stocks / NASDAQ / Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

Our Opinion

Syndax Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer.” (Page 1) Read the full document

Company Description

Syndax Pharmaceuticals, Inc., incorporated on October 11, 2005, is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. [Source: Reuters]

Company Website: